Found 9 matching trials
Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX PHASE3 Primary Objective:
To characterize the long-term safety and tolerability o...
Show More Status
Active Not Recruiting
Location
Phoenix Childrens Hospital Site Number : 8400009
Learn More & Join Trial
A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophilia PHASE3 This is a multicenter, multinational, open-label, one-way cross-over, Phase...
Show More Status
Active Not Recruiting
Location
Center for Inherited Blood Disorders (CIBD) Site Number : 8400012
Learn More & Join Trial
A Study of Fitusiran in Severe Hemophilia A and B Patients Previously Receiving Factor or Bypassing Agent Prophylaxis PHASE3 Primary Objective:
To characterize the frequency of bleeding episodes (BE)...
Show More Location
Investigational Site Number 0139
Learn More & Join Trial
A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors PHASE3 Primary Objective:
-To evaluate the efficacy of fitusiran compared to on-d...
Show More Location
Investigational Site Number 0140
Learn More & Join Trial
A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab PHASE4 This is an exploratory, single group, Phase 4, study to assess treatment wi...
Show More Location
Children's Hospital Los Angeles- Site Number : 8400005
Learn More & Join Trial
Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B PHASE2 Primary Objective:
\- To confirm appropriate dose levels of fitusiran when...
Show More Status
Active Not Recruiting
Location
Children's Hospital Los Angeles Site Number : 8400002
Learn More & Join Trial
An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or B PHASE1 Primary Objective:
To evaluate the long-term safety and tolerability of fi...
Show More Location
Clinical Trial Site
Learn More & Join Trial
A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors PHASE3 The purpose of this study was to determine the frequency of bleeding episod...
Show More Location
Investigational Site Number 0117
Learn More & Join Trial
A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B PHASE3 This is a parallel, Phase 3, two-arm, open-label study to evaluate the effi...
Show More Location
The Luskin Orthopaedic Institute for Children- Site Number : 8400013
Learn More & Join Trial